Skip to Main Content

Paper Details

Sodium selenate as a disease-modifying treatment for mild-moderate Alzheimer's disease: an open-label extension study.
BMJ Neurol Open
7
2021
Author NameAffiliation
Christopher M HovensUniversity of Melbourne
Terence J O'BrienMonash University
Terence J O'BrienUniversity of Melbourne
Terence J O'BrienRoyal Melbourne Hospital
Terence J O'BrienAlfred Hospital
  • 1 - 5

Datasets

Release 1.2